Medication info
Duistar Tablet 40/10mg

Duistar Tablet 40/10mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Il Yang Biopharm Co., Ltd.
Appearance
White and light blue, oval-shaped double-coated tablet with a convex surface on both sides
Packaging
30 tablets/PTP [10 tablets/PTPX3], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201701752 · Approved 2017.04.10

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, direct conversion to this drug may be considered when blood pressure is not adequately controlled with the individual components, as follows: - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, treatment should be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Older patients: The usual amlodipine dosage is recommended for older patients, but caution should be exercised when increasing the dose (see Section 3, “Patients Requiring Caution”). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
Child dose
Pediatric patients 18 years of age or younger: The safety and efficacy of this drug have not been established; therefore, its use is not recommended.

Ingredients

Manufacturer
Il Yang Biopharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medicine is used to effectively manage the blood pressure of patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of telmisartan or amlodipine.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, direct conversion to this drug may be considered when blood pressure is not adequately controlled with the individual components, as follows: - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, treatment should be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Older patients: The usual amlodipine dosage is recommended for older patients, but caution should be exercised when increasing the dose (see Section 3, “Patients Requiring Caution”). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.

Child dose

Pediatric patients 18 years of age or younger: The safety and efficacy of this drug have not been established; therefore, its use is not recommended.

Precautions

This medication should not be taken by pregnant women or women who may become pregnant, especially during the second and third trimesters, as it can cause serious harm to the fetus. Patients with allergies to this drug or certain liver disorders, heart issues, hypotension, kidney problems, etc., should avoid taking this medication. It is also advisable for nursing women not to use this drug. Patients with impaired liver or kidney function, as well as those with specific heart valve diseases, need to exercise special caution when using this medication, and dose adjustments or regular check-ups may be necessary. Side effects such as dizziness, swelling, and hypotension may occur while taking this drug, so if symptoms are severe or persistent, consulting healthcare professionals is necessary. Since this is a blood pressure-lowering medication, if symptoms of hypotension arise, appropriate measures such as lying down or receiving intravenous treatment should be taken immediately. There is a risk of elevated potassium levels in the blood, so caution is needed when taking potassium supplements or foods high in potassium, and regular blood tests are recommended. Patients with weak kidney function should undergo regular kidney function assessments before and after taking this medication, and safety for kidney transplant patients has not been sufficiently verified. This drug may interact with other medications, so it's essential to inform healthcare providers of any other medications being taken, especially when combined with certain heart medications, diuretics, antibiotics, steroids, etc. Elderly patients may be more sensitive to this medication, so starting with a lower dose and gradually increasing is advisable, and they should promptly inform healthcare professionals of any symptoms. In case of overdose, severe hypotension or heart problems may occur, so it is essential to strictly adhere to the prescribed dosage and not to increase it arbitrarily without a physician's directive. This drug is not recommended for children as safety and efficacy have not been sufficiently established in this population. During the treatment, caution should be taken when driving or operating hazardous machinery, as dizziness or drowsiness may occur.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusional state
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug eruption
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • acute kidney injury
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • weakness
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that does not allow light to enter. Additionally, to maintain the drug's efficacy, it should be stored at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White and light blue, oval-shaped double-coated tablet with a convex surface on both sides

Package unit

30 tablets/PTP [10 tablets/PTPX3], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.